Worldwide Healthcare Trust Plc (WWH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.002x

Based on the latest financial reports, Worldwide Healthcare Trust Plc (WWH) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-3.15 Million ≈ $-383.14 USD) by net assets (GBX1.44 Billion ≈ $175.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Worldwide Healthcare Trust Plc (WWH) balance sheet quality index to measure how much of total assets are equity-financed.

Worldwide Healthcare Trust Plc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Worldwide Healthcare Trust Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check WWH cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Worldwide Healthcare Trust Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Worldwide Healthcare Trust Plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Australian Agricultural Projects Ltd
AU:AAP
0.124x
Telefast Indonesia 
JK:TFAS
0.023x
Aerometrex Ltd
AU:AMX
0.254x
Memphasys Ltd
AU:MEM
-0.306x
N.C. Housing Public Company Limited
BK:NCH
0.024x
Hands Corporation Ltd
KO:143210
0.069x
Reko International Group Inc
V:REKO
-0.017x
Coats Group PLC
LSE:COA
0.184x

Annual Cash Flow Conversion Efficiency for Worldwide Healthcare Trust Plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Worldwide Healthcare Trust Plc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see WWH stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 GBX1.68 Billion
≈ $204.33K
GBX-1.54 Million
≈ $-187.86
-0.001x -184.56%
2024-03-31 GBX2.08 Billion
≈ $253.13K
GBX2.26 Million
≈ $275.22
0.001x -56.65%
2023-03-31 GBX2.15 Billion
≈ $261.68K
GBX5.39 Million
≈ $656.29
0.003x +142.68%
2022-03-31 GBX2.27 Billion
≈ $275.98K
GBX-13.33 Million
≈ $-1.62K
-0.006x -1603.13%
2021-03-31 GBX2.38 Billion
≈ $289.75K
GBX931.00K
≈ $113.28
0.000x -71.57%
2020-03-31 GBX1.54 Billion
≈ $187.17K
GBX2.12 Million
≈ $257.33
0.001x -6.90%
2019-03-31 GBX1.43 Billion
≈ $174.24K
GBX2.12 Million
≈ $257.33
0.001x -23.13%
2018-03-31 GBX1.10 Billion
≈ $133.95K
GBX2.12 Million
≈ $257.33
0.002x +132.42%
2015-03-31 GBX982.51 Million
≈ $119.54K
GBX-5.82 Million
≈ $-708.49
-0.006x -887.15%
2014-03-31 GBX636.19 Million
≈ $77.41K
GBX479.00K
≈ $58.28
0.001x -89.41%
2013-03-31 GBX504.42 Million
≈ $61.37K
GBX3.58 Million
≈ $436.19
0.007x -18.20%
2012-03-31 GBX391.80 Million
≈ $47.67K
GBX3.40 Million
≈ $414.17
0.009x --

About Worldwide Healthcare Trust Plc

LSE:WWH UK Asset Management
Market Cap
$17.47 Million
GBX143.62 Billion GBX
Market Cap Rank
#25525 Global
#274 in UK
Share Price
GBX380.00
Change (1 day)
-0.26%
52-Week Range
GBX307.50 - GBX397.00
All Time High
GBX397.00
About

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap … Read more